Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2003
03/05/2003EP1286997A1 6-phenylpyrrolopyrimidinedione derivatives
03/05/2003EP1286995A1 2,7-naphthyridine derivatives
03/05/2003EP1286994A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/05/2003EP1286992A1 Piperidyindoles as serotonin receptor ligands
03/05/2003EP1286990A1 Stolonoxides
03/05/2003EP1286986A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
03/05/2003EP1286984A2 Method for the preparation of tetrahydrobenzothiepines
03/05/2003EP1286982A2 Process for the preparation of benzoyl substituted bicylic compounds and chiral bnezopyran derivatives
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
03/05/2003EP1286974A2 Medicament for viral diseases
03/05/2003EP1286973A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
03/05/2003EP1286972A1 Pyrimidine compounds
03/05/2003EP1286971A1 (e)-7[4-(4-fluorophenyl)-6-isopropyl-2-mesylaminopyrimidin-5-yl]-(3r,5s)-dihydroxyhept-6-enoic acid
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286966A1 4-aminopiperidine derivatives and their use as medicine
03/05/2003EP1286964A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
03/05/2003EP1286962A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
03/05/2003EP1286957A1 Diphenylmethane derivatives
03/05/2003EP1286954A2 7-substituted fused ring tetracycline compounds
03/05/2003EP1286702A2 HMG CoA REDUCTASE INHIBITORS FOR PROMOTING ANGIOGENESIS
03/05/2003EP1286697A2 Method for selectively inhibiting ghrelin action
03/05/2003EP1286692A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
03/05/2003EP1286678A2 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer
03/05/2003EP1286676A1 Bismuth compounds for the treatment and prevention of mucositis
03/05/2003EP1286674A1 Methods and compositions for potentiating cancer chemotherapeutic agents
03/05/2003EP1286673A2 Ligands of integrin receptors
03/05/2003EP1286672A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
03/05/2003EP1286671A2 Compositions for the treatment of colorectal cancer comprising thalidomide and irinotecan
03/05/2003EP1286670A2 Use of therapeutic benzamide derivatives
03/05/2003EP1286669A2 Methods for prevention of ulcers and improving physiological performance
03/05/2003EP1286668A2 Pharmaceutical combinations and their use in treating gastrointestinal disorders
03/05/2003EP1286667A2 Composition for the treatment and/or the prevention of osteoporosis and/or inflammatory joint diseases
03/05/2003EP1286666A2 Starter kit for low dose oral contraceptives
03/05/2003EP1286665A2 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases
03/05/2003EP1286664A2 Method of treating immune pathologies with low dose estrogen
03/05/2003EP1286663A2 Encapsulating a toxic core within a non-toxic region in an oral dosage form
03/05/2003EP1286662A1 Tablets and methods for modified release of hydrophilic and other active agents
03/05/2003EP1286661A2 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
03/05/2003EP1286657A1 Nasal ointment based on white petroleum jelly
03/05/2003EP1286655A1 Topical composition containing at least one aryl oxime, and method for the preparation thereof
03/05/2003EP1286654A1 Use of aryl oximes for the prophylaxis and/or treatment of erythema formation and/or inflammatory reactions of the skin
03/05/2003EP1286653A1 Composition containing at least one aryl oxime and at least one active substance for treating acne and the use thereof
03/05/2003EP1286652A2 Skin protectant spray compositions
03/05/2003EP1286591A1 Treating smooth muscle hyperactivity with (r)-oxybutynin and (r)- desethyloxybutynin
03/05/2003EP1286590A2 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof
03/05/2003EP1266661A9 Anticancer compositions
03/05/2003EP1202984B1 diphenyl-piperidine derivate
03/05/2003EP1194427B1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv
03/05/2003EP1169316B1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
03/05/2003EP1140972B1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases
03/05/2003EP1140923B1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
03/05/2003EP1140893B1 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
03/05/2003EP1131059B1 Dry powder for inhalation
03/05/2003EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/05/2003EP1115406A4 Sustained release, and comfortable ophthalmic composition and method for ocular therapy
03/05/2003EP1109549B1 Analgesic use of podophyllotoxin for treating pain conditions in female genital organs
03/05/2003EP1089714B1 Processes to generate particles of water-insoluble compounds of up to 2000 nm in size
03/05/2003EP1084569B1 Androgens in combination with gestagens for compensating for a testosterone deficiency in men while simultaneously protecting the prostate
03/05/2003EP1082329B1 Platinum complex, its preparation and therapeutic application
03/05/2003EP1079826B1 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases
03/05/2003EP1063886B1 Disinfecting composition
03/05/2003EP1062214B1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels
03/05/2003EP1054859A4 Processes and intermediates useful to make antifolates
03/05/2003EP1051410B1 Benzo[b]pyran derivatives useful as external agents for the skin
03/05/2003EP1042278B1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
03/05/2003EP1026167B1 Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents
03/05/2003EP1021411B1 Benzamide derivatives as thrombin inhibitors
03/05/2003EP1006798A4 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
03/05/2003EP1003706B1 Cyclohexenone long-chain alcohol and medicament containing same
03/05/2003EP1001962B8 Production of avermectin compounds
03/05/2003EP0991641B1 Crystalline form of omeprazole sodium salt
03/05/2003EP0973514B1 In vivo polymerizable ophthalmic compositions
03/05/2003EP0969819B1 New crystalline form of omeprazole
03/05/2003EP0966447B1 Small molecules useful in the treatment of inflammatory disease
03/05/2003EP0964865B1 Pharmaceutically active tricyclic amines
03/05/2003EP0952829B1 Pharmaceutical composition of fenofibrate with high biological availability and method for preparing same
03/05/2003EP0946515B1 Parasiticidal pyrazoles
03/05/2003EP0941088B1 Use of conjugated linoleic acid to enhance natural killer lymphocyte function
03/05/2003EP0939628B1 Thiol sulfone metalloprotease inhibitors
03/05/2003EP0932387B1 Skin care compositions containing combinations of compounds for mimicking the effect on skin of retinoic acid
03/05/2003EP0930070B1 Stable aspirin ointment preparations
03/05/2003EP0920527A4 SYNTHESIS OF beta-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE
03/05/2003EP0912526B1 Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
03/05/2003EP0896577B1 Taxane derivatives having a Pyridyl substituted C13 side chain and their use as anti-tumor agents
03/05/2003EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
03/05/2003EP0892633B1 Use of inhibitors of the activity of retinoic acid for treating sensitive skin and/or acute damage induced by uv radiation
03/05/2003EP0882021B1 New phenanthridines
03/05/2003EP0877795A4 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
03/05/2003EP0874851B1 Macrocyclic compounds made from carbon suboxide units
03/05/2003EP0869807B1 Use of a medicament and use of mixture of substances to produce a medicament
03/05/2003EP0869786B1 Pharmaceutical compounds
03/05/2003EP0862916B1 topical use of vitamin D for the treatment of eye disorders
03/05/2003EP0853610B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/05/2003EP0845034B1 peptide having pronociceptive properties
03/05/2003EP0833626B1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders
03/05/2003EP0832069B1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION
03/05/2003EP0831830B1 Imidazole compounds
03/05/2003EP0801067B1 Novel quinuclidine derivatives and medicinal composition thereof
03/05/2003EP0792273B1 Bicyclic oxazine and thiazine oxazolidinone antibacterials
1 ... 5546 5547 5548 5549 5550 5551 5552 5553 5554 5555 5556 5557 5558 5559 5560 5561 5562 5563 5564 5565 5566 ... 7860